BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moon HH, Park SY, Kim JM, Park JB, Kwon CHD, Peck KR, Kim SJ, Lee SK, Joh JW. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area. Ann Transplant. 2017;22:338-345. [PMID: 28579606 DOI: 10.12659/aot.902989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_15] [Reference Citation Analysis]
3 Korayem GB, Alissa DA, AlSuhaibani NI, AlSwailem GS, AlShammari MA, Yaqoob I, Aljasser DS, Almaghrabi RS. Empiric vs screening-based use of isoniazid for tuberculosis prophylaxis: Safety and effectiveness in lung transplant recipients in Saudi Arabia. Transpl Infect Dis 2021;23:e13473. [PMID: 32978858 DOI: 10.1111/tid.13473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_15-1] [Reference Citation Analysis]
5 Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 [PMID: 31341356 DOI: 10.3748/wjg.v25.i26.3291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Philley JV, Griffith DE. Antimycobacterial Consideration in Transplantation Including Drug Non-susceptibility and Resistance: Tuberculosis and Nontuberculous Mycobacterial Disease. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_56] [Reference Citation Analysis]
7 Riccardi N, Cenderello G, Borroni E, Rutigliani M, Cirillo DM. A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis. BMC Infect Dis 2018;18:431. [PMID: 30157783 DOI: 10.1186/s12879-018-3347-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 . Antituberculars. Reactions Weekly 2017;1663:43-43. [DOI: 10.1007/s40278-017-34025-y] [Reference Citation Analysis]